首页 > 最新文献

Asian Journal of Research in Pharmaceutical Science最新文献

英文 中文
Thalidomide - The Disastrous Drug 沙利度胺——灾难性的药物
Pub Date : 2023-08-26 DOI: 10.52711/2231-5659.2023.00042
Rishabh Aggarwal, Anuj Nautiyal, Yogesh Joshi
In the late 1950s and the beginning of the 1960s, thalidomide was a medication that was frequently used to relieve nausea in pregnant women. Thalidomide treatment was shown to cause severe birth abnormalities in thousands of children in the 1960s. Thalidomide was an effective treatment for leprosy and later multiple myeloma, even though its usage was outlawed in the majority of nations at the time. Thalidomid treatment of pregnant leprosy patients has continued to result in deformities in rural areas of the world without major medical surveillance measures. Understanding of molecular targets is being improved through research into the mechanisms of thalidomide action. Safer medications might be created with a deeper understanding of these molecular targets. The thalidomide tragedy marked a turning point in toxicity testing because it compelled American and international regulatory agencies to create systematic toxicity testing protocols. In addition, the use of thalidomide as a developmental biology tool resulted in significant advancements in our understanding of the biochemical mechanisms underlying limb development. It is fitting to review the lessons learnt from the 1960s thalidomide disaster in honour of the Society of Toxicology's 50th anniversary, which also happens to be the same year that thalidomide was removed from the market.
在20世纪50年代末和60年代初,沙利度胺是一种经常用于缓解孕妇恶心的药物。在20世纪60年代,沙利度胺治疗被证明会导致数千名儿童严重的出生异常。沙利度胺是一种治疗麻风病和后来的多发性骨髓瘤的有效药物,尽管当时大多数国家都禁止使用沙利度胺。在世界上没有重大医疗监测措施的农村地区,对怀孕麻风病患者的沙利度胺治疗继续导致畸形。通过对沙利度胺作用机制的研究,对分子靶点的认识正在得到提高。随着对这些分子靶点的深入了解,可能会创造出更安全的药物。沙利度胺悲剧标志着毒性测试的一个转折点,因为它迫使美国和国际监管机构制定系统的毒性测试协议。此外,使用沙利度胺作为一种发育生物学工具,使我们对肢体发育的生化机制的理解取得了重大进展。在美国毒理学学会成立50周年之际,回顾上世纪60年代沙利度胺灾难的教训是恰当的。同年,沙利度胺被从市场上撤下。
{"title":"Thalidomide - The Disastrous Drug","authors":"Rishabh Aggarwal, Anuj Nautiyal, Yogesh Joshi","doi":"10.52711/2231-5659.2023.00042","DOIUrl":"https://doi.org/10.52711/2231-5659.2023.00042","url":null,"abstract":"In the late 1950s and the beginning of the 1960s, thalidomide was a medication that was frequently used to relieve nausea in pregnant women. Thalidomide treatment was shown to cause severe birth abnormalities in thousands of children in the 1960s. Thalidomide was an effective treatment for leprosy and later multiple myeloma, even though its usage was outlawed in the majority of nations at the time. Thalidomid treatment of pregnant leprosy patients has continued to result in deformities in rural areas of the world without major medical surveillance measures. Understanding of molecular targets is being improved through research into the mechanisms of thalidomide action. Safer medications might be created with a deeper understanding of these molecular targets. The thalidomide tragedy marked a turning point in toxicity testing because it compelled American and international regulatory agencies to create systematic toxicity testing protocols. In addition, the use of thalidomide as a developmental biology tool resulted in significant advancements in our understanding of the biochemical mechanisms underlying limb development. It is fitting to review the lessons learnt from the 1960s thalidomide disaster in honour of the Society of Toxicology's 50th anniversary, which also happens to be the same year that thalidomide was removed from the market.","PeriodicalId":8545,"journal":{"name":"Asian Journal of Research in Pharmaceutical Science","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135236982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative Characterization of Marketed Antacid Granules 市售抗酸颗粒的比较表征
Pub Date : 2023-08-26 DOI: 10.52711/2231-5659.2023.00035
Sakshi D. Dandgawal, Rahul Y. Pagar, Dhananjay M. Patil
Before inhibitors of the proton pump and antagonists of the H2 receptor, the mainstay of therapy was antacids for acid-peptic diseases. In this work different tests for characterization of different brands of antacid granules were carried out. This study set out to compare the quality of five antacid brands. Angle of repose, Bulk density, Tapped density, Carr's index, Hausner's ratio, Effervescent duration, Preliminary Antacid Test, Acid Neutralizing Capacity, Reheis Test, and Rosette Rice Test were used to compare the antacid granules. In the examination of several antacid granules available in the market, the values of bulk density, tapped density, angle of repose, carr's index, and hausner's ratio reveal that Brands A, B, and D have good flow property, Brand C has fair property, and Brand E has passable flow property. Brand A has a shorter effervescent time than other brands, while Brand D has a longer one. Because the antacid-acid (HCl) solution's pH for each brand is found to be greater than pH 3.5, all of the brands are considered to be antacids. The acid neutralizing capacity (ANC) test reveals that none of the antacid products meet the US FDA's requirement that they have an acid neutralizing capacity of at least 5 mEq. The Reheis test revealed that Brand B needed more time than other brands to neutralize, but Brand D needed less time. Brand A required less time than other brands to maintain the pH level between 3 and 5, while Brand D required more time, according to the Rosette rice test.
在质子泵抑制剂和H2受体拮抗剂出现之前,主要的治疗方法是抗酸剂治疗酸消化性疾病。本文对不同牌子的抗酸颗粒进行了不同的表征试验。本研究旨在比较五种抗酸剂品牌的质量。采用静息角、容重、密度、卡尔指数、豪斯纳比、泡腾时间、初步抗酸试验、中和酸能力、Reheis试验和莲叶试验对抗酸颗粒进行比较。通过对市面上几种抗酸颗粒的容重、攻丝密度、休止角、卡尔指数、豪斯纳比的测定,表明A、B、D型抗酸颗粒的流动性能较好,C型抗酸颗粒的流动性能一般,E型抗酸颗粒的流动性能尚可。A品牌的起泡时间比其他品牌短,而D品牌的起泡时间较长。因为每个品牌的抗酸-酸(HCl)溶液的pH值都大于pH值3.5,所以所有品牌都被认为是抗酸剂。酸中和能力(ANC)测试显示,抗酸剂产品不符合美国FDA的要求,他们的酸中和能力至少为5 mEq。Reheis测试显示,品牌B比其他品牌需要更多的时间来中和,而品牌D需要更少的时间。根据Rosette水稻试验,A牌水稻保持pH值在3到5之间所需的时间比其他品牌短,而D牌水稻需要的时间更长。
{"title":"Comparative Characterization of Marketed Antacid Granules","authors":"Sakshi D. Dandgawal, Rahul Y. Pagar, Dhananjay M. Patil","doi":"10.52711/2231-5659.2023.00035","DOIUrl":"https://doi.org/10.52711/2231-5659.2023.00035","url":null,"abstract":"Before inhibitors of the proton pump and antagonists of the H2 receptor, the mainstay of therapy was antacids for acid-peptic diseases. In this work different tests for characterization of different brands of antacid granules were carried out. This study set out to compare the quality of five antacid brands. Angle of repose, Bulk density, Tapped density, Carr's index, Hausner's ratio, Effervescent duration, Preliminary Antacid Test, Acid Neutralizing Capacity, Reheis Test, and Rosette Rice Test were used to compare the antacid granules. In the examination of several antacid granules available in the market, the values of bulk density, tapped density, angle of repose, carr's index, and hausner's ratio reveal that Brands A, B, and D have good flow property, Brand C has fair property, and Brand E has passable flow property. Brand A has a shorter effervescent time than other brands, while Brand D has a longer one. Because the antacid-acid (HCl) solution's pH for each brand is found to be greater than pH 3.5, all of the brands are considered to be antacids. The acid neutralizing capacity (ANC) test reveals that none of the antacid products meet the US FDA's requirement that they have an acid neutralizing capacity of at least 5 mEq. The Reheis test revealed that Brand B needed more time than other brands to neutralize, but Brand D needed less time. Brand A required less time than other brands to maintain the pH level between 3 and 5, while Brand D required more time, according to the Rosette rice test.","PeriodicalId":8545,"journal":{"name":"Asian Journal of Research in Pharmaceutical Science","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135236983","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cell Organelles: DNA 细胞器:DNA
Pub Date : 2023-08-26 DOI: 10.52711/2231-5659.2023.00045
Nandakumar R. Kadam, Poonam M. Kasar
The cellular components are called cell organelles. These cell organelles include both membrane and non-membrane bound organelles, present within the cells and are distinct in their structures and functions. They coordinate and function efficiently for the normal functioning of the cell. The cellular components are called cell organelles. These cell organelles include both membrane and non-membrane bound organelles, present within the cells and are distinct in their structures and functions. They coordinate and function efficiently for the normal functioning of the cell. A few of them function by providing shape and support, whereas some are involved in the locomotion and reproduction of a cell. There are various organelles present within the cell and are classified into three categories based on the presence or absence of membrane.
细胞成分称为细胞器。这些细胞器包括膜细胞器和非膜结合细胞器,它们存在于细胞内,在结构和功能上是不同的。它们协调并有效地维持细胞的正常功能。细胞成分称为细胞器。这些细胞器包括膜细胞器和非膜结合细胞器,它们存在于细胞内,在结构和功能上是不同的。它们协调并有效地维持细胞的正常功能。其中一些细胞的功能是提供形状和支撑,而另一些则参与细胞的运动和繁殖。细胞内有各种各样的细胞器,根据膜的存在与否可分为三类。
{"title":"Cell Organelles: DNA","authors":"Nandakumar R. Kadam, Poonam M. Kasar","doi":"10.52711/2231-5659.2023.00045","DOIUrl":"https://doi.org/10.52711/2231-5659.2023.00045","url":null,"abstract":"The cellular components are called cell organelles. These cell organelles include both membrane and non-membrane bound organelles, present within the cells and are distinct in their structures and functions. They coordinate and function efficiently for the normal functioning of the cell. The cellular components are called cell organelles. These cell organelles include both membrane and non-membrane bound organelles, present within the cells and are distinct in their structures and functions. They coordinate and function efficiently for the normal functioning of the cell. A few of them function by providing shape and support, whereas some are involved in the locomotion and reproduction of a cell. There are various organelles present within the cell and are classified into three categories based on the presence or absence of membrane.","PeriodicalId":8545,"journal":{"name":"Asian Journal of Research in Pharmaceutical Science","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135236984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patient Counseling – Role of Pharmacist 病人咨询-药剂师的角色
Pub Date : 2023-08-26 DOI: 10.52711/2231-5659.2023.00044
Poonam M Kasar, Chetan Sahebrao Salunke, Krishna Pralhad Patil
Effective patient counseling makes the patient understand his/her illness, necessary lifestyle modifications and pharmacotherapy in a better way and thus enhance patient compliance. The pharmacist has immense responsibility in counseling the patients. The counseling pharmacist should possess adequate knowledge and should be an effective communicator, making use of the verbal and non-verbal communication skills. The act of assisting a client in seeing everything clearly, potentially from a unique perspective. This might assist the client in focusing on feelings, experiences, or behaviour with the goal of achieving positive change and establishing a trusting connection. Confidentiality is essential for successful counselling.
有效的患者咨询可以使患者更好地了解自己的病情,必要的生活方式改变和药物治疗,从而提高患者的依从性。药剂师在给病人提供咨询方面负有巨大的责任。咨询药师应具备足够的知识,并应是一个有效的沟通者,利用语言和非语言沟通技巧。帮助客户从一个独特的角度看清楚一切的行为。这可能有助于来访者关注自己的感受、经历或行为,以实现积极的改变和建立信任的联系。保密是成功咨询的关键。
{"title":"Patient Counseling – Role of Pharmacist","authors":"Poonam M Kasar, Chetan Sahebrao Salunke, Krishna Pralhad Patil","doi":"10.52711/2231-5659.2023.00044","DOIUrl":"https://doi.org/10.52711/2231-5659.2023.00044","url":null,"abstract":"Effective patient counseling makes the patient understand his/her illness, necessary lifestyle modifications and pharmacotherapy in a better way and thus enhance patient compliance. The pharmacist has immense responsibility in counseling the patients. The counseling pharmacist should possess adequate knowledge and should be an effective communicator, making use of the verbal and non-verbal communication skills. The act of assisting a client in seeing everything clearly, potentially from a unique perspective. This might assist the client in focusing on feelings, experiences, or behaviour with the goal of achieving positive change and establishing a trusting connection. Confidentiality is essential for successful counselling.","PeriodicalId":8545,"journal":{"name":"Asian Journal of Research in Pharmaceutical Science","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135236985","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Microspheres: A Comprehensive Review 微球:综合综述
Pub Date : 2023-08-26 DOI: 10.52711/2231-5659.2023.00041
P. Usha Lakshmi, K. Tejaswini, B. Hemalatha, K. Padmalatha
Microspheres play a very important role as particulate drug delivery system because of their small size and other efficient properties. Microspheres have been proved to be a suitable bridge to scale the distance over to formulate an effective dosage form, to simulate controlled drug release. Microspheres are characteristically free flowing solid powders, which consist of proteins or synthetic polymer, which are biodegradable in nature. Microspheres having particle size in range between 0.1 - 200μm, can be delivered by several routes like oral, parentral, nasal, ophthalmic, transdermal, colonal etc. Various recent advancement in case of microspheres like mucoadhesive, hollow, floating, microballons, magnetic have been contributed to overcome the various problems that are associated with the use of microspheres, which includes site specific targeting and improved release kinetics. In future by combining various new strategies, microspheres will find a central place in novel drug delivery, particularly in diseased cell sorting, genetic materials, safe, targeting and effective drug delivery.
微球以其体积小、效率高等特点,在颗粒给药系统中发挥着重要的作用。微球已被证明是一个合适的桥梁,以扩大距离,制定有效的剂型,模拟药物的受控释放。微球的特点是自由流动的固体粉末,由蛋白质或合成聚合物组成,本质上是可生物降解的。微球的粒径范围在0.1 - 200μm之间,可通过口服、给药、鼻、眼、透皮、结肠等多种途径给药。微球的各种最新进展,如粘接、中空、漂浮、微球、磁性等,都有助于克服与微球使用相关的各种问题,包括位点特异性靶向和改进的释放动力学。未来,通过各种新策略的结合,微球将在新型药物递送,特别是在病变细胞分选、遗传材料、安全、靶向和有效的药物递送方面占据中心地位。
{"title":"Microspheres: A Comprehensive Review","authors":"P. Usha Lakshmi, K. Tejaswini, B. Hemalatha, K. Padmalatha","doi":"10.52711/2231-5659.2023.00041","DOIUrl":"https://doi.org/10.52711/2231-5659.2023.00041","url":null,"abstract":"Microspheres play a very important role as particulate drug delivery system because of their small size and other efficient properties. Microspheres have been proved to be a suitable bridge to scale the distance over to formulate an effective dosage form, to simulate controlled drug release. Microspheres are characteristically free flowing solid powders, which consist of proteins or synthetic polymer, which are biodegradable in nature. Microspheres having particle size in range between 0.1 - 200μm, can be delivered by several routes like oral, parentral, nasal, ophthalmic, transdermal, colonal etc. Various recent advancement in case of microspheres like mucoadhesive, hollow, floating, microballons, magnetic have been contributed to overcome the various problems that are associated with the use of microspheres, which includes site specific targeting and improved release kinetics. In future by combining various new strategies, microspheres will find a central place in novel drug delivery, particularly in diseased cell sorting, genetic materials, safe, targeting and effective drug delivery.","PeriodicalId":8545,"journal":{"name":"Asian Journal of Research in Pharmaceutical Science","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135236976","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmaceutical approach of Taro (Colocasia esculenta) 芋(Colocasia esculenta)的药学研究
Pub Date : 2023-08-26 DOI: 10.52711/2231-5659.2023.00040
Kirti Kubal, Kunal Dikwalkar, Akshay Rane, Palisha Hodawadekar, Amita Bhalekar, Nikita Dhuri, Shubham Chavan, Rohan Barse, Vijay Jagtap
Colocasia esculenta is a widely cultivated plant belonging to the family Araceae. It is commonly known as “Taro” the name was given to this family’s tubers and roots. It is an annual herbaceous plant with a long history of uses in traditional medicine and as a food in several countries. Taro is an extremely valuable source of carbohydrates as an energy source. It is rich in mucilage and starch granules. Traditionally, it has been employed in the treatment of asthma, arthritis, diarrhea, neuro disorders, and skin disorders. It possesses ingredients having antitumor, anti-diabetic, anti-microbial, anti-bacterial, anti-hepatotoxic, and anti-melanogenic properties. The literature survey carried out revealed that taro can serve as a potential film-forming agent, disintegrant, diluent, and granulating agent. The review revealed that taro can be used in the pharmaceutical industry for its various properties. Taro mucilage was found to be a suitable alternative to conventional mucilage’s in formulations and development. Also in this review, we described different extraction techniques used to extract mucilage from the corms of the taro plant. The review concluded that all parts of the taro plant are useful and have a variety of health benefits. The starch and the gum obtained from the corms of C. esculenta can be used in the pharmaceutical industries for its various properties such as in the form of binder, matrix forming agent etc.
土芋属天南星科,是一种广泛种植的植物。它通常被称为“芋头”,这个名字是给这个家庭的块茎和根。它是一种一年生草本植物,在传统医学中有着悠久的历史,在一些国家被用作食物。芋头是一种极有价值的碳水化合物能量来源。它富含粘液和淀粉颗粒。传统上,它被用于治疗哮喘、关节炎、腹泻、神经疾病和皮肤病。具有抗肿瘤、抗糖尿病、抗微生物、抗菌、抗肝毒、抗黑素等特性。文献调查表明,芋头可作为成膜剂、崩解剂、稀释剂和造粒剂。综述表明,芋头具有多种特性,可用于医药工业。芋头胶浆在配方和开发上都是一种适合于传统胶浆的替代品。此外,本文还介绍了从芋头球茎中提取粘液的不同提取技术。审查的结论是,芋头植物的所有部分都是有用的,有各种各样的健康益处。从牛蒡球茎中提取的淀粉和树胶具有粘结剂、基质形成剂等多种特性,可用于制药工业。
{"title":"Pharmaceutical approach of Taro (Colocasia esculenta)","authors":"Kirti Kubal, Kunal Dikwalkar, Akshay Rane, Palisha Hodawadekar, Amita Bhalekar, Nikita Dhuri, Shubham Chavan, Rohan Barse, Vijay Jagtap","doi":"10.52711/2231-5659.2023.00040","DOIUrl":"https://doi.org/10.52711/2231-5659.2023.00040","url":null,"abstract":"Colocasia esculenta is a widely cultivated plant belonging to the family Araceae. It is commonly known as “Taro” the name was given to this family’s tubers and roots. It is an annual herbaceous plant with a long history of uses in traditional medicine and as a food in several countries. Taro is an extremely valuable source of carbohydrates as an energy source. It is rich in mucilage and starch granules. Traditionally, it has been employed in the treatment of asthma, arthritis, diarrhea, neuro disorders, and skin disorders. It possesses ingredients having antitumor, anti-diabetic, anti-microbial, anti-bacterial, anti-hepatotoxic, and anti-melanogenic properties. The literature survey carried out revealed that taro can serve as a potential film-forming agent, disintegrant, diluent, and granulating agent. The review revealed that taro can be used in the pharmaceutical industry for its various properties. Taro mucilage was found to be a suitable alternative to conventional mucilage’s in formulations and development. Also in this review, we described different extraction techniques used to extract mucilage from the corms of the taro plant. The review concluded that all parts of the taro plant are useful and have a variety of health benefits. The starch and the gum obtained from the corms of C. esculenta can be used in the pharmaceutical industries for its various properties such as in the form of binder, matrix forming agent etc.","PeriodicalId":8545,"journal":{"name":"Asian Journal of Research in Pharmaceutical Science","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135236979","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hordenine - Unapproved Dietary Ingredient Hordenine -未经批准的膳食成分
Pub Date : 2023-08-26 DOI: 10.52711/2231-5659.2023.00038
C. Muralikrishna Goud, G. N. Pramodini, Raja Rajeshwari Kamisetti
The present work focuses on providing awareness to the users of dietary supplement containing hordenine an unapproved dietary ingredient causing severe side effects. Hordenine is a new dietary ingredient that hasn’t been submitted to FDA to establish its safety. Hordinine is an ingredient without GRAS status. The U.S. Food and Drug Administration (FDA) recently determined hordenine to be a “new dietary ingredient (NDI) for which an NDI notification is required and has not yet been submitted” and not an approved dietary ingredient under the Dietary Supplement Health and Education Act of 1994 (DSHEA). Therefore, any product containing hordenine is considered “adulterated”. Rapid heart rates and high blood pressure are the side effects of hordenine that are more likely to occur in sensitive sub-populations of people such as pregnant women and consumers with cardiovascular disease. Usage of hordenine should be avoided during surgeries because of its side effects i.e rapid heart rates and high blood pressure. Dietary supplement products containing hordinine are not safe for weight loss and improving athletic performances and should be avoided for consuming.
目前的工作重点是向含有hordenine的膳食补充剂的使用者提供意识,这是一种未经批准的膳食成分,会造成严重的副作用。Hordenine是一种新的膳食成分,尚未提交给FDA以确定其安全性。山葵碱是一种没有GRAS的成分。美国食品和药物管理局(FDA)最近确定,hordenine是一种“新的膳食成分(NDI),需要NDI通知,但尚未提交”,而不是1994年膳食补充剂健康和教育法(DSHEA)批准的膳食成分。因此,任何含有栀子碱的产品都被认为是“掺假”的。加速心率和高血压是hordenine的副作用,更容易发生在敏感人群中,如孕妇和患有心血管疾病的消费者。手术期间应避免使用hordenine,因为它的副作用是心率加快和高血压。含有蜂鸟碱的膳食补充剂对减肥和提高运动成绩是不安全的,应该避免食用。
{"title":"Hordenine - Unapproved Dietary Ingredient","authors":"C. Muralikrishna Goud, G. N. Pramodini, Raja Rajeshwari Kamisetti","doi":"10.52711/2231-5659.2023.00038","DOIUrl":"https://doi.org/10.52711/2231-5659.2023.00038","url":null,"abstract":"The present work focuses on providing awareness to the users of dietary supplement containing hordenine an unapproved dietary ingredient causing severe side effects. Hordenine is a new dietary ingredient that hasn’t been submitted to FDA to establish its safety. Hordinine is an ingredient without GRAS status. The U.S. Food and Drug Administration (FDA) recently determined hordenine to be a “new dietary ingredient (NDI) for which an NDI notification is required and has not yet been submitted” and not an approved dietary ingredient under the Dietary Supplement Health and Education Act of 1994 (DSHEA). Therefore, any product containing hordenine is considered “adulterated”. Rapid heart rates and high blood pressure are the side effects of hordenine that are more likely to occur in sensitive sub-populations of people such as pregnant women and consumers with cardiovascular disease. Usage of hordenine should be avoided during surgeries because of its side effects i.e rapid heart rates and high blood pressure. Dietary supplement products containing hordinine are not safe for weight loss and improving athletic performances and should be avoided for consuming.","PeriodicalId":8545,"journal":{"name":"Asian Journal of Research in Pharmaceutical Science","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135236978","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fast Dissolving Films: A Review 快速溶解薄膜:综述
Pub Date : 2023-08-26 DOI: 10.52711/2231-5659.2023.00037
Mansi Thakur, Isha Sharma, Michi Moda, Neha Sharma
Fast dissolving films for oral administration were a novel treatment option for individuals who had trouble swallowing pills or tablets. Hydrophilic polymers are used to create a film that quickly dissolves on the tongue. Upto 50-60% of all dosage forms, the traditional dosage forms (tablet and capsule) are widely accepted. For condition such as trigeminal neuralgia, Meniere’s disease and addiction, any buccal administration solutions have been commercialized or are being suggested. The type of drug delivery system known as an orally fast dissolving film dissolves or disintegrates in the oral cavity after being placed there in a matter of seconds without the need for water. Films are unconstructive, excellent mucoadhesion. Methods used for manufacturing of Fast dissolving films are solvent casting method, rolling. Evaluation test for fast dissolving films are hardness, friability. A new drug delivery technology for oral drug administration is fast-dissolving film. It was created using the transdermal patch's technology. The methods employed for Spray drying and freeze-drying are used to make fast-dissolving tablets. By creating an easy-to-use dosage form, Novel Pharmacological Delivery System (NDDS), a recent advancement, promises to improve the safety and effectiveness of currently used drug molecules improved patient compliance and better administration. To create a chemical entity, it takes a lot of money, effort, and time are necessary. Beneficial in situations where an extra quick onset of action is necessary, such as motion sickness, severe discomfort, allergic reactions, or coughing.
口服快速溶解薄膜是一种新的治疗选择,适用于吞咽药片或药片有困难的人。亲水聚合物被用来制造一种能在舌头上快速溶解的薄膜。在所有剂型中,高达50-60%的传统剂型(片剂和胶囊)被广泛接受。对于三叉神经痛、梅尼埃氏病和成瘾等疾病,任何口腔给药解决方案都已商业化或正在建议中。这种被称为口服快速溶解膜的药物输送系统在放入口腔后几秒钟内就会溶解或分解,而不需要水。膜是非建设性的,良好的黏附性。用于制造快速溶解薄膜的方法有溶剂铸造法、轧制法。速溶膜的评价试验是硬度、脆性。快速溶膜是一种新的口服给药技术。它是用透皮贴片的技术制造的。采用喷雾干燥法和冷冻干燥法制备快溶片。通过创造一种易于使用的剂型,新型药物传递系统(NDDS)有望提高目前使用药物分子的安全性和有效性,改善患者的依从性和更好的管理。要创造一个化学实体,需要大量的金钱、精力和时间。在需要快速行动的情况下是有益的,比如晕车、严重不适、过敏反应或咳嗽。
{"title":"Fast Dissolving Films: A Review","authors":"Mansi Thakur, Isha Sharma, Michi Moda, Neha Sharma","doi":"10.52711/2231-5659.2023.00037","DOIUrl":"https://doi.org/10.52711/2231-5659.2023.00037","url":null,"abstract":"Fast dissolving films for oral administration were a novel treatment option for individuals who had trouble swallowing pills or tablets. Hydrophilic polymers are used to create a film that quickly dissolves on the tongue. Upto 50-60% of all dosage forms, the traditional dosage forms (tablet and capsule) are widely accepted. For condition such as trigeminal neuralgia, Meniere’s disease and addiction, any buccal administration solutions have been commercialized or are being suggested. The type of drug delivery system known as an orally fast dissolving film dissolves or disintegrates in the oral cavity after being placed there in a matter of seconds without the need for water. Films are unconstructive, excellent mucoadhesion. Methods used for manufacturing of Fast dissolving films are solvent casting method, rolling. Evaluation test for fast dissolving films are hardness, friability. A new drug delivery technology for oral drug administration is fast-dissolving film. It was created using the transdermal patch's technology. The methods employed for Spray drying and freeze-drying are used to make fast-dissolving tablets. By creating an easy-to-use dosage form, Novel Pharmacological Delivery System (NDDS), a recent advancement, promises to improve the safety and effectiveness of currently used drug molecules improved patient compliance and better administration. To create a chemical entity, it takes a lot of money, effort, and time are necessary. Beneficial in situations where an extra quick onset of action is necessary, such as motion sickness, severe discomfort, allergic reactions, or coughing.","PeriodicalId":8545,"journal":{"name":"Asian Journal of Research in Pharmaceutical Science","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135236980","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Survey Based Assessment of Adverse Effect in Covid-19 Vaccination Breakthrough Infections 基于调查的新型冠状病毒疫苗突破感染不良反应评价
Pub Date : 2023-08-26 DOI: 10.52711/2231-5659.2023.00034
Jubershaha Fakir, Khemchand R. Surana, Dhananjay M. Patil, Deepak D. Sonawane
Background: Millions of individuals worldwide have been impacted by COVID-19, which has put a tremendous strain on global economies and healthcare systems. Vaccines are the only way to stop this pandemic, unfortunately. The COVID-19 vaccines were developed more swiftly than previous immunizations and have received global Emergency Use Authorization (EUA) approval. Therefore, our goal was to assess any short-term negative consequences following vaccination. The purpose of this study is to determine the negative effects linked to three different COVID-19 vaccination types. The questionnaire asked questions on COVID-19 infection and the adverse effects of the COVID-19 vaccine after receiving the first, second, or booster dose. Method: With the help of questionnaires from different districts, a cross-sectional study was done. We made the questionnaire and used it to find out things like which side effects happen most often after the first, second, and booster doses of a vaccine. We also find out how many people get the Corona virus after getting the vaccine. Result: People often experience bad side effects like fever, nausea, diarrhoea, weakness, headache, chills with shivering, pain at the injection site, loss of appetite, and weight loss. Even though many people don't have any problems after getting a vaccine, Most of the time, we found that only 4% of people who got the vaccine got the Corona virus. Conclusion: As more people get sick after getting the Covishield vaccine, it may not work as well as the Covaxin and Sputnik V vaccines.
背景:全球有数百万人受到COVID-19的影响,这给全球经济和医疗保健系统带来了巨大压力。不幸的是,疫苗是阻止这场大流行的唯一途径。COVID-19疫苗的开发速度比以前的免疫接种更快,并已获得全球紧急使用授权(EUA)批准。因此,我们的目标是评估接种疫苗后的任何短期负面后果。本研究的目的是确定与三种不同的COVID-19疫苗类型相关的负面影响。该问卷询问了关于COVID-19感染和接种第一剂、第二剂或加强剂后COVID-19疫苗的不良反应的问题。方法:采用不同地区的调查问卷进行横断面研究。我们做了一份调查问卷,用它来找出一些事情,比如在第一剂、第二剂和加强剂接种疫苗后,哪种副作用最常发生。我们还发现有多少人在接种疫苗后感染了冠状病毒。结果:人们经常会出现发热、恶心、腹泻、虚弱、头痛、打寒战、注射部位疼痛、食欲不振和体重减轻等不良副作用。尽管很多人在接种疫苗后没有任何问题,但大多数时候,我们发现只有4%的接种疫苗的人感染了冠状病毒。结论:随着越来越多的人在接种Covishield疫苗后患病,它的效果可能不如Covaxin和Sputnik V疫苗。
{"title":"Survey Based Assessment of Adverse Effect in Covid-19 Vaccination Breakthrough Infections","authors":"Jubershaha Fakir, Khemchand R. Surana, Dhananjay M. Patil, Deepak D. Sonawane","doi":"10.52711/2231-5659.2023.00034","DOIUrl":"https://doi.org/10.52711/2231-5659.2023.00034","url":null,"abstract":"Background: Millions of individuals worldwide have been impacted by COVID-19, which has put a tremendous strain on global economies and healthcare systems. Vaccines are the only way to stop this pandemic, unfortunately. The COVID-19 vaccines were developed more swiftly than previous immunizations and have received global Emergency Use Authorization (EUA) approval. Therefore, our goal was to assess any short-term negative consequences following vaccination. The purpose of this study is to determine the negative effects linked to three different COVID-19 vaccination types. The questionnaire asked questions on COVID-19 infection and the adverse effects of the COVID-19 vaccine after receiving the first, second, or booster dose. Method: With the help of questionnaires from different districts, a cross-sectional study was done. We made the questionnaire and used it to find out things like which side effects happen most often after the first, second, and booster doses of a vaccine. We also find out how many people get the Corona virus after getting the vaccine. Result: People often experience bad side effects like fever, nausea, diarrhoea, weakness, headache, chills with shivering, pain at the injection site, loss of appetite, and weight loss. Even though many people don't have any problems after getting a vaccine, Most of the time, we found that only 4% of people who got the vaccine got the Corona virus. Conclusion: As more people get sick after getting the Covishield vaccine, it may not work as well as the Covaxin and Sputnik V vaccines.","PeriodicalId":8545,"journal":{"name":"Asian Journal of Research in Pharmaceutical Science","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135236987","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Short Review on Prickly Pear Fruit Opuntia spp 刺梨果实科综述
Pub Date : 2023-08-26 DOI: 10.52711/2231-5659.2023.00039
Karishma. P. Bhadane, Rutuja. T. Bedse, Rajesh. D. Ahire, D. A. Patil
In India, a significant portion of the population has settled in dry rain-fed areas that need perennial vegetation to protect them from erosion. The use of drought tolerant and economically viable plants appears to be an option to sustain livelihoods, reduce poverty and create employment opportunities. Prickly pear is drought tolerant due to its carbon dioxide fixation pathway (CAM), well suited to dry zones where it can be used as an alternative food and fodder as well as a hedge to protect agricultural fields. In the seventh century, the British introduced cacti to India to produce cochineal dye, but these plantations gradually disappeared due to pests and flooding of the areas. Recent attempts to introduce the cultivated cactus pear began in the late 1980s. In addition to the adaptation trials, some other aspects have been studied in the country: plant productivity, nutritional aspects, salinity tolerance, fruit quality, etc., which are briefly described in this article.
在印度,很大一部分人口定居在干旱的雨养地区,这些地区需要多年生植被来保护他们免受侵蚀。使用耐旱和经济上可行的植物似乎是维持生计、减少贫困和创造就业机会的一种选择。由于其二氧化碳固定途径(CAM),刺梨具有耐旱性,非常适合干旱地区,在那里它可以用作替代食物和饲料,也可以用作保护农田的篱笆。7世纪时,英国人将仙人掌引进印度,用于生产胭脂虫染料,但由于虫害和洪水泛滥,这些种植园逐渐消失。最近的引进栽培仙人掌梨的尝试始于20世纪80年代末。除适应性试验外,国内还进行了一些其他方面的研究:植物生产力、营养方面、耐盐性、果实品质等,本文对此作简要介绍。
{"title":"A Short Review on Prickly Pear Fruit Opuntia spp","authors":"Karishma. P. Bhadane, Rutuja. T. Bedse, Rajesh. D. Ahire, D. A. Patil","doi":"10.52711/2231-5659.2023.00039","DOIUrl":"https://doi.org/10.52711/2231-5659.2023.00039","url":null,"abstract":"In India, a significant portion of the population has settled in dry rain-fed areas that need perennial vegetation to protect them from erosion. The use of drought tolerant and economically viable plants appears to be an option to sustain livelihoods, reduce poverty and create employment opportunities. Prickly pear is drought tolerant due to its carbon dioxide fixation pathway (CAM), well suited to dry zones where it can be used as an alternative food and fodder as well as a hedge to protect agricultural fields. In the seventh century, the British introduced cacti to India to produce cochineal dye, but these plantations gradually disappeared due to pests and flooding of the areas. Recent attempts to introduce the cultivated cactus pear began in the late 1980s. In addition to the adaptation trials, some other aspects have been studied in the country: plant productivity, nutritional aspects, salinity tolerance, fruit quality, etc., which are briefly described in this article.","PeriodicalId":8545,"journal":{"name":"Asian Journal of Research in Pharmaceutical Science","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135236977","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Asian Journal of Research in Pharmaceutical Science
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1